GX BIO LABS · Product artwork
A synthetic tuftsin-related peptide investigated in laboratory studies of GABA-associated gene expression.
10 available
View COA for 10 mg1 batch report available
Not for human or veterinary administration. Listed strength is a supplied specification; see the matching batch report for measured results.
1 report is available for this strength. Match the batch number on your supplied material.
View available COAsSelank is a seven-amino-acid peptide related to the immunopeptide tuftsin. Researchers have examined whether it influences signalling associated with GABA, an inhibitory neurotransmitter. In a 2017 study, human-derived IMR-32 neuroblastoma cells were exposed to Selank, GABA, olanzapine or combinations of these substances. Selank alone did not change the measured expression of the tested genes. Combining it with the other substances changed the expression patterns observed with those substances alone. This cell model explores possible molecular interactions; it cannot establish anxiety relief, clinical combination effects or treatment safety in people.
Each source identifies what was studied and the limits of its findings. Published research is separate from this product’s batch COA.
Selank alone produced no measured gene-expression changes. Combinations with GABA or olanzapine altered responses in cultured neuroblastoma cells; clinical outcomes were not studied.
Read studySelank is currently listed in 10 mg. Select a strength above to see its price, product image and current stock. Listed quantities are supplied specifications, not measured batch results.
1 laboratory report is published for this compound. Match the selected strength and available batch identifiers, and open the original document to check the actual test scope.
A catalogue listing is not a laboratory measurement. Check original documentation for the selected strength and batch before relying on identity, purity or quantity information.
A synthetic seven-amino-acid peptide studied in rat neurotrophin signalling and peptide-binding experiments.
PT-141, also known as bremelanotide, is a melanocortin-receptor agonist studied in defined clinical populations with sexual dysfunction.
A synthetic tripeptide investigated in cell models of oxidative stress, viability and proliferation.
Delta-sleep-inducing peptide has been examined in small historical studies of sleep recordings and daytime function, with inconsistent findings.